Clinical Trial Update: A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 study evaluating a dextromethorphan and bupropion sustained-release tablet for major depressive disorder; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Dextromethorphan and bupropion sustained-release tablets

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder (MDD) | Phase 3 | Status: RECRUITING